Amount of qualified sufferers: CDEC talked about the uncertainty in the volume of people with reasonably serious to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Scientific specialists consulted by CADTH indicated that some patients who will be labeled as possessing gentle or average condition might have a severe https://andreyzbbb.bloggip.com/35877328/about-hemgenix